Insulinoma initially misdiagnosed as migraine
Insulinoma is a rare functional neuroendocrine tumor of pancreatic islet cells that produces excessive insulin leading to neuroglycopenic and autonomic symptoms relieved by glucose. We report a case of a 39-year-old woman with recurrent neuroglycopenic symptoms for nearly five years, initially misdiagnosed as migraine, until she presented to ED with a collapse secondary to hypoglycemia. Biochemical confirmation was obtained during a supervised 72-hour fast, with symptomatic hypoglycemia which showed lowest glucose levels of 1.7mmol/L, elevated C-peptide levels of 2,271pmol/L, high insulin levels of 83.5 mU/L and a negative sulfonylurea screen. Imaging demonstrated a large hyper enhancing pancreatic mass, confirmed by <sup>68</sup>Ga-DOTATATE PET as a solitary lesion without metastasis. Histopathology revealed a well-differentiated Grade 1 neuroendocrine tumor measuring 90×65×40 mm. Following surgical intervention, she demonstrated a successful recovery. This case emphasizes the need to consider insulinoma early in the differential diagnosis of recurrent neuroglycopenic episodes to prevent serious complications and avoid inappropriate treatments.
Authors
- Abed M. Zaitoun (ORCID: https://orcid.org/0000-0003-3351-6460)
- Iftekhar Ahmed (ORCID: https://orcid.org/0000-0003-4642-5023)
- Javeria Hameed
Institutions
- Nottingham University Hospitals NHS Trust (GB)
- University of Nottingham (GB)
- Queen's Medical Centre (GB)
Publication Details
- Journal
- Archive of Clinical Cases
- Published
- 2025-09-22
- DOI
- https://doi.org/10.22551/2025.48.1203.10325
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00